| Literature DB >> 35927736 |
Ranran Liu1, Fuli Kong1, Siyuan Xing1, Zhengxiao He1, Lu Bai1, Jiahong Sun1, Xiaodong Tan1, Di Zhao1, Guiping Zhao2, Jie Wen3.
Abstract
BACKGROUND: Chicken is the most consumed meat worldwide and the industry has been facing challenging myopathies. Wooden breast (WB), which is often accompanied by white striping (WS), is a serious myopathy adversely affecting meat quality of breast muscles. The underlying lipid metabolic mechanism of WB affected broilers is not fully understood.Entities:
Keywords: Broiler chicken; Lipid profile; Liver; Serum; Wooden breast
Year: 2022 PMID: 35927736 PMCID: PMC9354336 DOI: 10.1186/s40104-022-00743-x
Source DB: PubMed Journal: J Anim Sci Biotechnol ISSN: 1674-9782
The breast muscle fillet indicators between the control and WB affected groups
| Category | Control | WB | WB + WS |
|---|---|---|---|
| WB score | 0 | 2.0 | 2.0 |
| WS score | 0 | 0 | 1.0 |
| Compression force, N | 2.57 ± 0.87 | 5.77 ± 1.00*** | 6.50 ± 0.45*** |
| Serum CK, U/mL | 5.39 ± 2.08 | 8.59 ± 2.01** | 11.54 ± 1.83*** |
**P < 0.01; ***P < 0.001
Fig. 1Histopathological observation of breast muscle in the control, WB and WB + WS groups. A, B The normal breast exhibited well-organized myofibers with a characteristic polygonal shape. C, D The WB group with irregular muscle cell morphology and myofiber degeneration and regeneration (arrows). E, F The WB + WS group with collagen deposition and dissolved myofibers (arrows)
Fig. 2Lipid profiles in the control, WB and WB + WS chicken breast muscles. A Percentages of different lipid categories. PC, phosphatidylcholine; PE, phosphatidylethanolamine; TG, triglyceride; CL, cardiolipin; SM, sphingomyelin; FA, fatty acid; Cer, ceramides; PG, phosphatidylglycerol; PI, phosphatidylinositol; others included: CerP (1.25%), ceramide phosphate; LPC (1.07%), lysophosphatidylcholine; AcCa (0.71%), acyl carnitine; DG (0.54%), diglyceride; HexlCer (0.54%), simple Glc series; PA (0.54%), phosphatidic acid; PS (0.54%), phosphatidylserine; Co (0.36%), coenzyme; LPE (0.18%), lysophosphatidylethanolamine; LPS (0.18%), lysophosphatidylserine; SPHP (0.18%), Sphingosine phosphate. B Principal component analysis plot of lipidomics samples in the control, WB, and WB + WS groups. C Heatmap of significantly different lipid molecule categories affected by WB and WB + WS. Red cells and green cells in the heatmap represent increased and decreased lipids, respectively. D The relative differences in lipid content of different categories between the control and affected groups. LPE, LPS, PA, Cerp, PG, PI, CL, and FA were acquired in negative ion mode. Hex1Cer, AcCa, LPC, Cer, PS, SPHP, DG, Co, PE, SM, and TG were obtained in positive ion mode
The numbers of differential abundance lipid molecules in different lipid categories of the WB affected breasts compared with the controls
| Lipids/Groups | Neutral lipids | Phospholipids | Sphingolipid | Others | Total | Percentage, % | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| TG | Others | PC | PE | Others | SM | Others | ||||
| WB | 225 | 40.2 | ||||||||
| Up | 92 | – | – | – | – | 1 | 4 | 1 | 97 | 17.3 |
| Down | – | – | 55 | 52 | – | 13 | 6 | 2 | 128 | 22.9 |
| WB + WS | 225 | 40.2 | ||||||||
| Up | 95 | 5 | 1 | 2 | 1 | 5 | 7 | – | 116 | 20.7 |
| Down | 3 | – | 61 | 36 | 1 | 7 | 1 | – | 109 | 19.5 |
Fig. 3Shared differential abundance (DA) lipid molecules and the FA compositions in the control, WB and WB + WS chicken breast muscles. A, B The shared DA lipid molecules of TGs in affected groups with more than 2.5-fold change compared to the controls. C, D The shared DA lipid molecules of PCs and PEs in affected groups with less than 1.5-fold change compared to the controls. E Percentages of MUFAs, PUFAs, and SFAs in breast muscle FAs composition between the control and affected groups
The numbers of increased and decreased lipid molecules in different lipid categories of the WB affected group compared with the control group
| Tissues | Lipids/Groups | Total | Percentage, % | Differential lipid molecules |
|---|---|---|---|---|
| Liver | WB | 29 | 6.7 | 17 lipid molecules increased (Neutral lipids: 10, Phospholipids: 7) 12 lipid molecules decreased (Phospholipids: 6, Sphingolipid: 4;Others: 2) |
| WB + WS | 61 | 14.1 | 39 lipid molecules increased (Neutral lipids: 2, Phospholipids: 29; Sphingolipid: 8) 22 lipid molecules decreased (Phospholipids: 19, Sphingolipid: 3) | |
| Serum | WB | 4 | 0.8 | 3 lipid molecules increased (Sphingolipid: 3) 1 lipid molecules decreased (Sphingolipid: 1) |
| WB + WS | 44 | 8.3 | 31 lipid molecules increased (Neutral lipids: 6, Phospholipids: 3; Sphingolipid: 22) 13 lipid molecules decreased (Neutral lipids: 4;Phospholipids: 7; Sphingolipid: 2) |
Fig. 4The shared differential abundance (DA) of lipid molecules between different tissues. A The shared DA lipid molecules of WB + WS groups between liver and serum. B The changing of FAs composition in breast muscle and serum when compared WB + WS groups to controls. MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids (*P < 0.05, ** P < 0.01, *** P < 0.001)